Deletions and loss-of-function variants in TP63 associated with orofacial clefting-Reference-Cited by-同舟云学术

Deletions and loss-of-function variants in TP63 associated with orofacial clefting

Published:2019-03-08 Issue:7 Volume:27 Page:1101-1112
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Khandelwal Kriti D.,van den Boogaard Marie-José H.,Mehrem Sarah L.,Gebel Jakob,Fagerberg Christina^ORCID,van Beusekom Ellen,van Binsbergen Ellen,Topaloglu Ozan,Steehouwer Marloes,Gilissen Christian^ORCID,Ishorst Nina,van Rooij Iris A. L. M.,Roeleveld Nel,Christensen Kaare,Schoenaers Joseph,Bergé Stefaan,Murray Jeffrey C.,Hens Greet,Devriendt Koen^ORCID,Ludwig Kerstin U.^ORCID,Mangold Elisabeth,Hoischen Alexander,Zhou Huiqing^ORCID,Dötsch Volker^ORCID,Carels Carine E. L.^ORCID,van Bokhoven Hans^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://www.nature.com/articles/s41431-019-0370-0.pdf

Reference28 articles.

1. Mills AA, Zheng B, Wang X-J, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398:708–13.

2. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398:714–8.

3. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2:305–16.